BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24595201)

  • 21. Reversal effects of L-arginine treatment on blood pressure and vascular responsiveness of streptozotocin-diabetic rats.
    Ozçelikay AT; Tay A; Güner S; Taşyaran V; Yildizoğlu-Ari N; Dinçer UD; Altan VM
    Pharmacol Res; 2000 Feb; 41(2):201-9. PubMed ID: 10623488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atorvastatin treatment prevents alterations in coronary smooth muscle nuclear Ca2+ signaling in diabetic dyslipidemia.
    Wamhoff BR; Dixon JL; Sturek M
    J Vasc Res; 2002; 39(3):208-20. PubMed ID: 12097819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin transporter protein in pulmonary hypertensive rats treated with atorvastatin.
    Laudi S; Trump S; Schmitz V; West J; McMurtry IF; Mutlak H; Christians U; Weimann J; Kaisers U; Steudel W
    Am J Physiol Lung Cell Mol Physiol; 2007 Sep; 293(3):L630-8. PubMed ID: 17575010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
    Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
    J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atorvastatin and sildenafil lower blood pressure and improve endothelial dysfunction, but only atorvastatin increases vascular stores of nitric oxide in hypertension.
    Guimarães DA; Rizzi E; Ceron CS; Pinheiro LC; Gerlach RF; Tanus-Santos JE
    Redox Biol; 2013; 1(1):578-85. PubMed ID: 24363994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuation of contractile dysfunction by atorvastatin after intestinal ischemia reperfusion injury in rats.
    Ozacmak VH; Sayan H; Igdem AA; Cetin A; Ozacmak ID
    Eur J Pharmacol; 2007 May; 562(1-2):138-47. PubMed ID: 17335801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of atorvastatin on regional arterial stiffness in patients with type 2 diabetes mellitus.
    Shinohara K; Shoji T; Kimoto E; Yokoyama H; Fujiwara S; Hatsuda S; Maeno T; Shoji T; Fukumoto S; Emoto M; Koyama H; Nishizawa Y
    J Atheroscler Thromb; 2005; 12(4):205-10. PubMed ID: 16141624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats.
    Ceylan-Isik A; Hünkar T; Aşan E; Kaymaz F; Ari N; Söylemezoğlu T; Renda N; Soncul H; Bali M; Karasu C;
    J Pharm Pharmacol; 2007 Dec; 59(12):1629-41. PubMed ID: 18053324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased atherosclerosis in diabetic dyslipidemic swine: protection by atorvastatin involves decreased VLDL triglycerides but minimal effects on the lipoprotein profile.
    Dixon JL; Shen S; Vuchetich JP; Wysocka E; Sun GY; Sturek M
    J Lipid Res; 2002 Oct; 43(10):1618-29. PubMed ID: 12364546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice.
    Verschuren L; Kleemann R; Offerman EH; Szalai AJ; Emeis SJ; Princen HM; Kooistra T
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):161-7. PubMed ID: 15514207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of atorvastatin and pravastatin on glucose tolerance in diabetic rats mildly induced by streptozotocin.
    Kanda M; Satoh K; Ichihara K
    Biol Pharm Bull; 2003 Dec; 26(12):1681-4. PubMed ID: 14646170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atorvastatin 10 mg plus ezetimibe 10mg compared with atorvastatin 20 mg: impact on the lipid profile in Japanese patients with abnormal glucose tolerance and coronary artery disease.
    Uemura Y; Watarai M; Ishii H; Koyasu M; Takemoto K; Yoshikawa D; Shibata R; Matsubara T; Murohara T
    J Cardiol; 2012 Jan; 59(1):50-6. PubMed ID: 22100058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteocalcin Improves Metabolic Profiles, Body Composition and Arterial Stiffening in an Induced Diabetic Rat Model.
    Huang L; Yang L; Luo L; Wu P; Yan S
    Exp Clin Endocrinol Diabetes; 2017 Apr; 125(4):234-240. PubMed ID: 28073125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beneficial effects of Chinese prescription Kangen-karyu on diabetes associated with hyperlipidemia, advanced glycation endproducts, and oxidative stress in streptozotocin-induced diabetic rats.
    Kim HY; Okamoto T; Yokozawa T
    J Ethnopharmacol; 2009 Jul; 124(2):263-9. PubMed ID: 19397970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of atorvastatin on the regeneration of pancreatic {beta}-cells after streptozotocin treatment in the neonatal rodent.
    Marchand KC; Arany EJ; Hill DJ
    Am J Physiol Endocrinol Metab; 2010 Jul; 299(1):E92-E100. PubMed ID: 20388824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of atorvastatin and ezetimibe treatment on serum lipid profile and oxidative state in rats fed with a high-cholesterol diet.
    Yasim A; Ozbag D; Kilinc M; Ciralik H; Toru H; Gümüşalan Y
    Am J Med Sci; 2010 May; 339(5):448-52. PubMed ID: 20224310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress.
    Briones AM; Rodríguez-Criado N; Hernanz R; García-Redondo AB; Rodrigues-Díez RR; Alonso MJ; Egido J; Ruiz-Ortega M; Salaices M
    Hypertension; 2009 Jul; 54(1):142-9. PubMed ID: 19451411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antioxidant and triglyceride-lowering effects of vitamin E associated with the prevention of abnormalities in the reactivity and morphology of aorta from streptozotocin-diabetic rats. Antioxidants in Diabetes-Induced Complications (ADIC) Study Group.
    Karasu C; Ozansoy G; Bozkurt O; Erdoğan D; Omeroğlu S
    Metabolism; 1997 Aug; 46(8):872-9. PubMed ID: 9258267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Additive beneficial effects of amlodipine and atorvastatin in reversing advanced cardiac hypertrophy in elderly spontaneously hypertensive rats.
    Lu JC; Cui W; Zhang HL; Liu F; Han M; Liu DM; Yin HN; Zhang K; Du J
    Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1110-9. PubMed ID: 19413592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chrysin and luteolin attenuate diabetes-induced impairment in endothelial-dependent relaxation: effect on lipid profile, AGEs and NO generation.
    El-Bassossy HM; Abo-Warda SM; Fahmy A
    Phytother Res; 2013 Nov; 27(11):1678-84. PubMed ID: 23296950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.